Continuous infusional topotecan in advanced breast and non-small-cell lung cancer: no evidence of increased efficacy.

por Mainwaring, P. N., Nicolson, M. C., Hickish, T., Penson, R., Joel, S., Slevin, M., Smith, I. E.
Publicado 1997

Single-agent paclitaxel in patients with previously untreated stage IV epithelial ovarian cancer. London Gynaecological Oncology and North Thames Gynaecological Oncology Groups.

por Gore, M. E., Rustin, G., Slevin, M., Gallagher, C., Penson, R., Osborne, R., Ledermann, J., Cameron, T., Thompson, J. M.
Publicado 1997

A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumours

por Penson, R T, Seiden, M V, Matulonis, U A, Appleman, L J, Fuller, A F, Goodman, A, Campos, S M, Clark, J W, Roche, M, Eder, J P
Publicado 2005

A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with s...

por Lassen, U, Molife, L R, Sorensen, M, Engelholm, S-A, Vidal, L, Sinha, R, Penson, R T, Buhl-Jensen, P, Crowley, E, Tjornelund, J, Knoblauch, P, de Bono, J S
Publicado 2010